Lung Cancer
Volume 45 , Pages S59-S61 , August 2004

Staging and response to therapy of malignant pleural mesothelioma

  • Robert Heelan

      Affiliations

    • Corresponding Author InformationTel.: +1-212-610-0707; fax: +1-212-308-1393.

References 

  1. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax. 1976;31:15–24
  2. Mattson K. Natural history and clinical staging of malignant mesothelioma (abstract). Eur J Respir Dis 1982;(Suppl):63–87.
  3. Rusch VW, Ginsberg RJ. New concepts in the staging of mesotheliomas. In: Deslauriers J, Lacquet LK, editors. Thoracic surgery: surgical management of pleural diseases. St. Louis: Mosby, 1990. pp. 336–43.
  4. Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul P, Ledoray V. Thoracoscopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. II. Prognosis and staging. Cancer. 1993;72:394–404
  5. Dimitrov NV, McMahon S. Presentation, diagnostic methods, staging, and natural history of malignant mesothelioma. In: Antman K, Asiner J, editors. Asbestos-related malignancy. Orlando, FL: Grune & Stratton, 1987. pp. 225–38.
  6. Tammilehto L, Kivisaari L, Salminen US, Maasilta P, Mattson K. Evaluation of the clinical TNM staging system for malignant pleural mesothelioma: an assessment in 88 patients. Lung Cancer. 1995;12:25–34
  7. Patz EF, Shaffer K, Piwnica-Worms DR, Jochelson M, Sarin M, Sugarbaker DJ, et al.  Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability. Am. J. Roentgenol. 1992;159:961–966
  8. Rusch VW, editor. The International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122–28.
  9. Patz EF, Rusch VW, Heelan R. The proposed new international TNM staging system for malignant pleural mesothelioma: application to imaging. Am. J. Roentgenol. 1996;66:323–327
  10. Sugarbaker DJ, Strauss GM, Lynch TJ, Richards W, Mentzer SJ, Lee TH, et al.  Node status has prognostic significance in the multimodality therapy of diffuse, malignant mesothelioma. J. Clin. Oncol. 1993;11:172–178
  11. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. Am. J. Roentgenol. 1999;172:1039–1047
  12. Rusch VW, Venkatraman E. The importance of surgical staging in the treatment of malignant pleural mesothelioma. J. Thorac. Cardiovasc. Surg. 1996;111:815–826
  13. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207–214
  14. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al.  New guidelines to evaluate the response to treatment in solid tumors. J. Natl. Cancer Inst. 2000;92:205–216

PII: S0169-5002(04)00173-4

doi: 10.1016/j.lungcan.2004.04.013

Lung Cancer
Volume 45 , Pages S59-S61 , August 2004

Article Tools